Dimerix

Dimerix EBIT CAGR 5Y

The EBIT CAGR (5 Year) of Dimerix (DXB.AX) as of Oct 19, 2026 is 27.75 %. In the previous year, EBIT CAGR (5 Year) was 27.75 % — a change of 0.00% (lower).

EBIT CAGR 5Y

27.75 %

YoY

0.00%

Last updated:

EBIT CAGR (5 Year) of Dimerix is 2026 27.75 % . EBIT CAGR (5 Year) of Dimerix was 2025 27.75 % . It decreases by 0.00% lower compared to the previous year.

The Dimerix EBIT CAGR 5Y history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT CAGR 5Y
Date
EBIT CAGR 5Y
Jan 1, 2019
27.75 AUD
Jan 1, 2020
27.75 AUD
Jan 1, 2021
27.75 AUD
Jan 1, 2022
27.75 AUD
Jan 1, 2023
27.75 AUD
Jan 1, 2024
27.75 AUD
Jan 1, 2025
27.75 AUD
Jan 1, 2026
27.75 AUD
The Dimerix EBIT CAGR 5Y history
YEAREBIT CAGR 5YYoY
27.75 %0.00%
27.75 %0.00%
27.75 %0.00%
27.75 %0.00%
27.75 %0.00%
27.75 %0.00%
27.75 %0.00%
27.75 %0.00%
27.75 %0.00%
27.75 %0.00%
27.75 %0.00%
27.75 %0.00%
27.75 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dimerix Stock analysis

What does Dimerix do? Dimerix Ltd is an Australian biotechnology company specializing in the development of innovative therapies for various medical needs. Their business model is based on identifying new targets for drug development, often through collaborations with other biotech or pharmaceutical companies. Dimerix focuses on cancer therapy, utilizing their innovative platform technology to identify and test a variety of drug candidates. They also have a pipeline of medications for kidney and lung diseases, as well as inflammation and pain. Dimerix actively seeks partnerships with other companies and research institutions to bring innovative therapies to market. One of their key products, DMX-200, is currently in phase II clinical trials for the treatment of kidney diseases and has shown promising results. Overall, Dimerix is well-positioned to continue bringing successful therapies to market in the future. Dimerix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Dimerix stock

EBIT CAGR (5 Year) of Dimerix is 27.75 % in 2026.

On Eulerpool you can find the complete historical development of EBIT CAGR (5 Year) Dimerix since 2006 – with annual values, charts, and detailed analysis.

The 5-year EBIT CAGR shows the compound annual growth rate of EBIT over the past five years.

To evaluate EBIT CAGR (5 Year)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT CAGR (5 Year).

EBIT CAGR (5 Year)'s is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT CAGR (5 Year)'s Dimerix historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Dimerix

All Key Metrics — Dimerix